ARCHIVES

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill

September 27, 1996

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Decision On Status Of Frederickson, DeVita Due In Month, Schweiker Says

May 1, 1981

Health Organizations: Cancer Center, Organization Join to Promote Awareness Of Skin Cancer

April 11, 1997